The global market for Natural Killer (NK) Cell Therapeutics was estimated to be worth US$ 255.8 million in 2023 and is forecast to a readjusted size of US$ 324.8 million by 2030 with a CAGR of 3.4% during the forecast period 2024-2030

Natural Killer (NK) Cell Therapeutics - Market

Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.

The Americas natural killer cells therapeutics market share accounted for the highest share 52.3% in 2019.

Based on application, the market is classified into cancer, gastrointestinal diseases and others. The cancer segment accounted for a major share in 2019 (66.99%).

Major players operating in the market include Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics and etc. The Top 6 players accounted for 96.66% of the global revenue market share in 2019.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Natural Killer (NK) Cell Therapeutics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Natural Killer (NK) Cell Therapeutics by region & country, by Type, and by Application.

The Natural Killer (NK) Cell Therapeutics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Natural Killer (NK) Cell Therapeutics.

Market Segmentation

Scope of Natural Killer (NK) Cell Therapeutics - Market Report

Report Metric	Details
Report Name	Natural Killer (NK) Cell Therapeutics - Market
Forecasted market size in 2030	US$ 324.8 million
CAGR	3.4%
Forecasted years	2024 - 2030
Segment by Type:	Mogamulizumab Lorvotuzumab Mertansine Others
Segment by Application	Cancer Cardiovascular Diseases Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Chipscreen Biosciences, Affimed NV, Altor BioScience, Innate Pharma, Takeda, Sorrento Therapeutics, NantKwest, Bristol-Myers Squibb, NKT, Henry Ford Health Services
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Natural Killer (NK) Cell Therapeutics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Natural Killer (NK) Cell Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Natural Killer (NK) Cell Therapeutics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Natural Killer (NK) Cell Therapeutics - Market size in 2030?

Ans: The Natural Killer (NK) Cell Therapeutics - Market size in 2030 will be US$ 324.8 million.

What is the Natural Killer (NK) Cell Therapeutics - Market share by region?

Ans: The Americas natural killer cells therapeutics market share accounted for the highest share 52.3% in 2019.

What is the Natural Killer (NK) Cell Therapeutics - Market share by application?

Ans: The cancer segment accounted for a major share in 2019 (66.99%).

What is the market share of major companies in Natural Killer (NK) Cell Therapeutics - Market?

Ans: The Top 6 players accounted for 96.66% of the global revenue market share in 2019.

Who are the main players in the Natural Killer (NK) Cell Therapeutics - Market report?

Ans: The main players in the Natural Killer (NK) Cell Therapeutics - Market are Chipscreen Biosciences, Affimed NV, Altor BioScience, Innate Pharma, Takeda, Sorrento Therapeutics, NantKwest, Bristol-Myers Squibb, NKT, Henry Ford Health Services

What are the Application segmentation covered in the Natural Killer (NK) Cell Therapeutics - Market report?

Ans: The Applications covered in the Natural Killer (NK) Cell Therapeutics - Market report are Cancer, Cardiovascular Diseases, Others

What are the Type segmentation covered in the Natural Killer (NK) Cell Therapeutics - Market report?

Ans: The Types covered in the Natural Killer (NK) Cell Therapeutics - Market report are Mogamulizumab, Lorvotuzumab Mertansine, Others

1 Market Overview

1.1 Natural Killer (NK) Cell Therapeutics Product Introduction

1.2 Global Natural Killer (NK) Cell Therapeutics Market Size Forecast

1.3 Natural Killer (NK) Cell Therapeutics Market Trends & Drivers

1.3.1 Natural Killer (NK) Cell Therapeutics Industry Trends

1.3.2 Natural Killer (NK) Cell Therapeutics Market Drivers & Opportunity

1.3.3 Natural Killer (NK) Cell Therapeutics Market Challenges

1.3.4 Natural Killer (NK) Cell Therapeutics Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Natural Killer (NK) Cell Therapeutics Players Revenue Ranking (2023)

2.2 Global Natural Killer (NK) Cell Therapeutics Revenue by Company (2019-2024)

2.3 Key Companies Natural Killer (NK) Cell Therapeutics Manufacturing Base Distribution and Headquarters

2.4 Key Companies Natural Killer (NK) Cell Therapeutics Product Offered

2.5 Key Companies Time to Begin Mass Production of Natural Killer (NK) Cell Therapeutics

2.6 Natural Killer (NK) Cell Therapeutics Market Competitive Analysis

2.6.1 Natural Killer (NK) Cell Therapeutics Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Natural Killer (NK) Cell Therapeutics Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer (NK) Cell Therapeutics as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Mogamulizumab

3.1.2 Lorvotuzumab Mertansine

3.1.3 Others

3.2 Global Natural Killer (NK) Cell Therapeutics Sales Value by Type

3.2.1 Global Natural Killer (NK) Cell Therapeutics Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Natural Killer (NK) Cell Therapeutics Sales Value, by Type (2019-2030)

3.2.3 Global Natural Killer (NK) Cell Therapeutics Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Cancer

4.1.2 Cardiovascular Diseases

4.1.3 Others

4.2 Global Natural Killer (NK) Cell Therapeutics Sales Value by Application

4.2.1 Global Natural Killer (NK) Cell Therapeutics Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Natural Killer (NK) Cell Therapeutics Sales Value, by Application (2019-2030)

4.2.3 Global Natural Killer (NK) Cell Therapeutics Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Natural Killer (NK) Cell Therapeutics Sales Value by Region

5.1.1 Global Natural Killer (NK) Cell Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Natural Killer (NK) Cell Therapeutics Sales Value by Region (2019-2024)

5.1.3 Global Natural Killer (NK) Cell Therapeutics Sales Value by Region (2025-2030)

5.1.4 Global Natural Killer (NK) Cell Therapeutics Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Natural Killer (NK) Cell Therapeutics Sales Value, 2019-2030

5.2.2 North America Natural Killer (NK) Cell Therapeutics Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Natural Killer (NK) Cell Therapeutics Sales Value, 2019-2030

5.3.2 Europe Natural Killer (NK) Cell Therapeutics Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Natural Killer (NK) Cell Therapeutics Sales Value, 2019-2030

5.4.2 Asia Pacific Natural Killer (NK) Cell Therapeutics Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Natural Killer (NK) Cell Therapeutics Sales Value, 2019-2030

5.5.2 South America Natural Killer (NK) Cell Therapeutics Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Natural Killer (NK) Cell Therapeutics Sales Value, 2019-2030

5.6.2 Middle East & Africa Natural Killer (NK) Cell Therapeutics Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Natural Killer (NK) Cell Therapeutics Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Natural Killer (NK) Cell Therapeutics Sales Value

6.3 United States

6.3.1 United States Natural Killer (NK) Cell Therapeutics Sales Value, 2019-2030

6.3.2 United States Natural Killer (NK) Cell Therapeutics Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Natural Killer (NK) Cell Therapeutics Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Natural Killer (NK) Cell Therapeutics Sales Value, 2019-2030

6.4.2 Europe Natural Killer (NK) Cell Therapeutics Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Natural Killer (NK) Cell Therapeutics Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Natural Killer (NK) Cell Therapeutics Sales Value, 2019-2030

6.5.2 China Natural Killer (NK) Cell Therapeutics Sales Value by Type (%), 2023 VS 2030

6.5.3 China Natural Killer (NK) Cell Therapeutics Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Natural Killer (NK) Cell Therapeutics Sales Value, 2019-2030

6.6.2 Japan Natural Killer (NK) Cell Therapeutics Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Natural Killer (NK) Cell Therapeutics Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Natural Killer (NK) Cell Therapeutics Sales Value, 2019-2030

6.7.2 South Korea Natural Killer (NK) Cell Therapeutics Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Natural Killer (NK) Cell Therapeutics Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Natural Killer (NK) Cell Therapeutics Sales Value, 2019-2030

6.8.2 Southeast Asia Natural Killer (NK) Cell Therapeutics Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Natural Killer (NK) Cell Therapeutics Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Natural Killer (NK) Cell Therapeutics Sales Value, 2019-2030

6.9.2 India Natural Killer (NK) Cell Therapeutics Sales Value by Type (%), 2023 VS 2030

6.9.3 India Natural Killer (NK) Cell Therapeutics Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Chipscreen Biosciences

7.1.1 Chipscreen Biosciences Profile

7.1.2 Chipscreen Biosciences Main Business

7.1.3 Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Products, Services and Solutions

7.1.4 Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Revenue (US$ Million) & (2019-2024)

7.1.5 Chipscreen Biosciences Recent Developments

7.2 Affimed NV

7.2.1 Affimed NV Profile

7.2.2 Affimed NV Main Business

7.2.3 Affimed NV Natural Killer (NK) Cell Therapeutics Products, Services and Solutions

7.2.4 Affimed NV Natural Killer (NK) Cell Therapeutics Revenue (US$ Million) & (2019-2024)

7.2.5 Affimed NV Recent Developments

7.3 Altor BioScience

7.3.1 Altor BioScience Profile

7.3.2 Altor BioScience Main Business

7.3.3 Altor BioScience Natural Killer (NK) Cell Therapeutics Products, Services and Solutions

7.3.4 Altor BioScience Natural Killer (NK) Cell Therapeutics Revenue (US$ Million) & (2019-2024)

7.3.5 Innate Pharma Recent Developments

7.4 Innate Pharma

7.4.1 Innate Pharma Profile

7.4.2 Innate Pharma Main Business

7.4.3 Innate Pharma Natural Killer (NK) Cell Therapeutics Products, Services and Solutions

7.4.4 Innate Pharma Natural Killer (NK) Cell Therapeutics Revenue (US$ Million) & (2019-2024)

7.4.5 Innate Pharma Recent Developments

7.5 Takeda

7.5.1 Takeda Profile

7.5.2 Takeda Main Business

7.5.3 Takeda Natural Killer (NK) Cell Therapeutics Products, Services and Solutions

7.5.4 Takeda Natural Killer (NK) Cell Therapeutics Revenue (US$ Million) & (2019-2024)

7.5.5 Takeda Recent Developments

7.6 Sorrento Therapeutics

7.6.1 Sorrento Therapeutics Profile

7.6.2 Sorrento Therapeutics Main Business

7.6.3 Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Products, Services and Solutions

7.6.4 Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Revenue (US$ Million) & (2019-2024)

7.6.5 Sorrento Therapeutics Recent Developments

7.7 NantKwest

7.7.1 NantKwest Profile

7.7.2 NantKwest Main Business

7.7.3 NantKwest Natural Killer (NK) Cell Therapeutics Products, Services and Solutions

7.7.4 NantKwest Natural Killer (NK) Cell Therapeutics Revenue (US$ Million) & (2019-2024)

7.7.5 NantKwest Recent Developments

7.8 Bristol-Myers Squibb

7.8.1 Bristol-Myers Squibb Profile

7.8.2 Bristol-Myers Squibb Main Business

7.8.3 Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Products, Services and Solutions

7.8.4 Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Revenue (US$ Million) & (2019-2024)

7.8.5 Bristol-Myers Squibb Recent Developments

7.9 NKT

7.9.1 NKT Profile

7.9.2 NKT Main Business

7.9.3 NKT Natural Killer (NK) Cell Therapeutics Products, Services and Solutions

7.9.4 NKT Natural Killer (NK) Cell Therapeutics Revenue (US$ Million) & (2019-2024)

7.9.5 NKT Recent Developments

7.10 Henry Ford Health Services

7.10.1 Henry Ford Health Services Profile

7.10.2 Henry Ford Health Services Main Business

7.10.3 Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Products, Services and Solutions

7.10.4 Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Revenue (US$ Million) & (2019-2024)

7.10.5 Henry Ford Health Services Recent Developments

8 Industry Chain Analysis

8.1 Natural Killer (NK) Cell Therapeutics Industrial Chain

8.2 Natural Killer (NK) Cell Therapeutics Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Natural Killer (NK) Cell Therapeutics Sales Model

8.5.2 Sales Channel

8.5.3 Natural Killer (NK) Cell Therapeutics Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Chipscreen Biosciences

Sorrento Therapeutics

NantKwest Inc

Bristol–Myers Squibb

NKT

Henry Ford Health Services

List of Tables

Table 1. Natural Killer (NK) Cell Therapeutics Market Trends

Table 2. Natural Killer (NK) Cell Therapeutics Market Drivers & Opportunity

Table 3. Natural Killer (NK) Cell Therapeutics Market Challenges

Table 4. Natural Killer (NK) Cell Therapeutics Market Restraints

Table 5. Global Natural Killer (NK) Cell Therapeutics Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Natural Killer (NK) Cell Therapeutics Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Natural Killer (NK) Cell Therapeutics Product Type

Table 9. Key Companies Time to Begin Mass Production of Natural Killer (NK) Cell Therapeutics

Table 10. Global Natural Killer (NK) Cell Therapeutics Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer (NK) Cell Therapeutics as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Natural Killer (NK) Cell Therapeutics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Natural Killer (NK) Cell Therapeutics Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Natural Killer (NK) Cell Therapeutics Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Natural Killer (NK) Cell Therapeutics Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Natural Killer (NK) Cell Therapeutics Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Natural Killer (NK) Cell Therapeutics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Natural Killer (NK) Cell Therapeutics Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Natural Killer (NK) Cell Therapeutics Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Natural Killer (NK) Cell Therapeutics Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Natural Killer (NK) Cell Therapeutics Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Natural Killer (NK) Cell Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Natural Killer (NK) Cell Therapeutics Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Natural Killer (NK) Cell Therapeutics Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Natural Killer (NK) Cell Therapeutics Sales Value by Region (2019-2024) & (%)

Table 27. Global Natural Killer (NK) Cell Therapeutics Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Natural Killer (NK) Cell Therapeutics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Natural Killer (NK) Cell Therapeutics Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Natural Killer (NK) Cell Therapeutics Sales Value, (2025-2030) & (US$ Million)

Table 31. Chipscreen Biosciences Basic Information List

Table 32. Chipscreen Biosciences Description and Business Overview

Table 33. Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Products, Services and Solutions

Table 34. Revenue (US$ Million) in Natural Killer (NK) Cell Therapeutics Business of Chipscreen Biosciences (2019-2024)

Table 35. Chipscreen Biosciences Recent Developments

Table 36. Affimed NV Basic Information List

Table 37. Affimed NV Description and Business Overview

Table 38. Affimed NV Natural Killer (NK) Cell Therapeutics Products, Services and Solutions

Table 39. Revenue (US$ Million) in Natural Killer (NK) Cell Therapeutics Business of Affimed NV (2019-2024)

Table 40. Affimed NV Recent Developments

Table 41. Altor BioScience Basic Information List

Table 42. Altor BioScience Description and Business Overview

Table 43. Altor BioScience Natural Killer (NK) Cell Therapeutics Products, Services and Solutions

Table 44. Revenue (US$ Million) in Natural Killer (NK) Cell Therapeutics Business of Altor BioScience (2019-2024)

Table 45. Altor BioScience Recent Developments

Table 46. Innate Pharma Basic Information List

Table 47. Innate Pharma Description and Business Overview

Table 48. Innate Pharma Natural Killer (NK) Cell Therapeutics Products, Services and Solutions

Table 49. Revenue (US$ Million) in Natural Killer (NK) Cell Therapeutics Business of Innate Pharma (2019-2024)

Table 50. Innate Pharma Recent Developments

Table 51. Takeda Basic Information List

Table 52. Takeda Description and Business Overview

Table 53. Takeda Natural Killer (NK) Cell Therapeutics Products, Services and Solutions

Table 54. Revenue (US$ Million) in Natural Killer (NK) Cell Therapeutics Business of Takeda (2019-2024)

Table 55. Takeda Recent Developments

Table 56. Sorrento Therapeutics Basic Information List

Table 57. Sorrento Therapeutics Description and Business Overview

Table 58. Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Products, Services and Solutions

Table 59. Revenue (US$ Million) in Natural Killer (NK) Cell Therapeutics Business of Sorrento Therapeutics (2019-2024)

Table 60. Sorrento Therapeutics Recent Developments

Table 61. NantKwest Basic Information List

Table 62. NantKwest Description and Business Overview

Table 63. NantKwest Natural Killer (NK) Cell Therapeutics Products, Services and Solutions

Table 64. Revenue (US$ Million) in Natural Killer (NK) Cell Therapeutics Business of NantKwest (2019-2024)

Table 65. NantKwest Recent Developments

Table 66. Bristol-Myers Squibb Basic Information List

Table 67. Bristol-Myers Squibb Description and Business Overview

Table 68. Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Products, Services and Solutions

Table 69. Revenue (US$ Million) in Natural Killer (NK) Cell Therapeutics Business of Bristol-Myers Squibb (2019-2024)

Table 70. Bristol-Myers Squibb Recent Developments

Table 71. NKT Basic Information List

Table 72. NKT Description and Business Overview

Table 73. NKT Natural Killer (NK) Cell Therapeutics Products, Services and Solutions

Table 74. Revenue (US$ Million) in Natural Killer (NK) Cell Therapeutics Business of NKT (2019-2024)

Table 75. NKT Recent Developments

Table 76. Henry Ford Health Services Basic Information List

Table 77. Henry Ford Health Services Description and Business Overview

Table 78. Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Products, Services and Solutions

Table 79. Revenue (US$ Million) in Natural Killer (NK) Cell Therapeutics Business of Henry Ford Health Services (2019-2024)

Table 80. Henry Ford Health Services Recent Developments

Table 81. Key Raw Materials Lists

Table 82. Raw Materials Key Suppliers Lists

Table 83. Natural Killer (NK) Cell Therapeutics Downstream Customers

Table 84. Natural Killer (NK) Cell Therapeutics Distributors List

Table 85. Research Programs/Design for This Report

Table 86. Key Data Information from Secondary Sources

Table 87. Key Data Information from Primary Sources

Table 88. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Natural Killer (NK) Cell Therapeutics Product Picture

Figure 2. Global Natural Killer (NK) Cell Therapeutics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Natural Killer (NK) Cell Therapeutics Sales Value (2019-2030) & (US$ Million)

Figure 4. Natural Killer (NK) Cell Therapeutics Report Years Considered

Figure 5. Global Natural Killer (NK) Cell Therapeutics Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Natural Killer (NK) Cell Therapeutics Revenue in 2023

Figure 7. Natural Killer (NK) Cell Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Mogamulizumab Picture

Figure 9. Lorvotuzumab Mertansine Picture

Figure 10. Others Picture

Figure 11. Global Natural Killer (NK) Cell Therapeutics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 12. Global Natural Killer (NK) Cell Therapeutics Sales Value Market Share by Type, 2023 & 2030

Figure 13. Product Picture of Cancer

Figure 14. Product Picture of Cardiovascular Diseases

Figure 15. Product Picture of Others

Figure 16. Global Natural Killer (NK) Cell Therapeutics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 17. Global Natural Killer (NK) Cell Therapeutics Sales Value Market Share by Application, 2023 & 2030

Figure 18. North America Natural Killer (NK) Cell Therapeutics Sales Value (2019-2030) & (US$ Million)

Figure 19. North America Natural Killer (NK) Cell Therapeutics Sales Value by Country (%), 2023 VS 2030

Figure 20. Europe Natural Killer (NK) Cell Therapeutics Sales Value (2019-2030) & (US$ Million)

Figure 21. Europe Natural Killer (NK) Cell Therapeutics Sales Value by Country (%), 2023 VS 2030

Figure 22. Asia Pacific Natural Killer (NK) Cell Therapeutics Sales Value (2019-2030) & (US$ Million)

Figure 23. Asia Pacific Natural Killer (NK) Cell Therapeutics Sales Value by Country (%), 2023 VS 2030

Figure 24. South America Natural Killer (NK) Cell Therapeutics Sales Value (2019-2030) & (US$ Million)

Figure 25. South America Natural Killer (NK) Cell Therapeutics Sales Value by Country (%), 2023 VS 2030

Figure 26. Middle East & Africa Natural Killer (NK) Cell Therapeutics Sales Value (2019-2030) & (US$ Million)

Figure 27. Middle East & Africa Natural Killer (NK) Cell Therapeutics Sales Value by Country (%), 2023 VS 2030

Figure 28. Key Countries/Regions Natural Killer (NK) Cell Therapeutics Sales Value (%), (2019-2030)

Figure 29. United States Natural Killer (NK) Cell Therapeutics Sales Value, (2019-2030) & (US$ Million)

Figure 30. United States Natural Killer (NK) Cell Therapeutics Sales Value by Type (%), 2023 VS 2030

Figure 31. United States Natural Killer (NK) Cell Therapeutics Sales Value by Application (%), 2023 VS 2030

Figure 32. Europe Natural Killer (NK) Cell Therapeutics Sales Value, (2019-2030) & (US$ Million)

Figure 33. Europe Natural Killer (NK) Cell Therapeutics Sales Value by Type (%), 2023 VS 2030

Figure 34. Europe Natural Killer (NK) Cell Therapeutics Sales Value by Application (%), 2023 VS 2030

Figure 35. China Natural Killer (NK) Cell Therapeutics Sales Value, (2019-2030) & (US$ Million)

Figure 36. China Natural Killer (NK) Cell Therapeutics Sales Value by Type (%), 2023 VS 2030

Figure 37. China Natural Killer (NK) Cell Therapeutics Sales Value by Application (%), 2023 VS 2030

Figure 38. Japan Natural Killer (NK) Cell Therapeutics Sales Value, (2019-2030) & (US$ Million)

Figure 39. Japan Natural Killer (NK) Cell Therapeutics Sales Value by Type (%), 2023 VS 2030

Figure 40. Japan Natural Killer (NK) Cell Therapeutics Sales Value by Application (%), 2023 VS 2030

Figure 41. South Korea Natural Killer (NK) Cell Therapeutics Sales Value, (2019-2030) & (US$ Million)

Figure 42. South Korea Natural Killer (NK) Cell Therapeutics Sales Value by Type (%), 2023 VS 2030

Figure 43. South Korea Natural Killer (NK) Cell Therapeutics Sales Value by Application (%), 2023 VS 2030

Figure 44. Southeast Asia Natural Killer (NK) Cell Therapeutics Sales Value, (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Natural Killer (NK) Cell Therapeutics Sales Value by Type (%), 2023 VS 2030

Figure 46. Southeast Asia Natural Killer (NK) Cell Therapeutics Sales Value by Application (%), 2023 VS 2030

Figure 47. India Natural Killer (NK) Cell Therapeutics Sales Value, (2019-2030) & (US$ Million)

Figure 48. India Natural Killer (NK) Cell Therapeutics Sales Value by Type (%), 2023 VS 2030

Figure 49. India Natural Killer (NK) Cell Therapeutics Sales Value by Application (%), 2023 VS 2030

Figure 50. Natural Killer (NK) Cell Therapeutics Industrial Chain

Figure 51. Natural Killer (NK) Cell Therapeutics Manufacturing Cost Structure

Figure 52. Channels of Distribution (Direct Sales, and Distribution)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-26D6003

Sat Oct 12 00:00:00 UTC 2024

Add to Cart

Global Chemotherapy Chairs Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-26D13514

Sat Oct 12 00:00:00 UTC 2024

Add to Cart

Drugs for Non-Small Cell Lung Cancer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-33S12067

Fri Oct 11 00:00:00 UTC 2024

Add to Cart

Oncological Phototherapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-11U13658

Tue Oct 08 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Natural Killer (NK) Cell Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-5C13853

Natural Killer (NK) Cell Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

FEATURED COMPANIES

Natural Killer (NK) Cell Therapeutics - Market Size

Natural Killer (NK) Cell Therapeutics - Market

Report Scope

Scope of Natural Killer (NK) Cell Therapeutics - Market Report

Chapter Outline

FAQ for this report

What is the Natural Killer (NK) Cell Therapeutics - Market size in 2030?

What is the Natural Killer (NK) Cell Therapeutics - Market share by region?

What is the Natural Killer (NK) Cell Therapeutics - Market share by application?

What is the market share of major companies in Natural Killer (NK) Cell Therapeutics - Market?

Who are the main players in the Natural Killer (NK) Cell Therapeutics - Market report?

What are the Application segmentation covered in the Natural Killer (NK) Cell Therapeutics - Market report?

What are the Type segmentation covered in the Natural Killer (NK) Cell Therapeutics - Market report?

FEATURED COMPANIES

RELATED REPORTS